Estimating the burden of adult hospital admissions due to RSV and other respiratory pathogens in England

Respiratory syncytial virus (RSV) is a common seasonal respiratory virus and an important cause of illness among infants, but the burden of RSV disease is not well described among the older population. The objective of this study was to estimate the age‐specific incidence of hospital admission among over 65 s due to respiratory illnesses attributable to RSV in England to inform optimal vaccine and therapeutic interventions.

• Publication year

  2021

• Venue

  Influenza and Other Respiratory Viruses

• Publication date

  2021-08-05

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/irv.12910PMID 34658161PMCID 8692807
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence of Respiratory Syncytial Virus Infection among Hospitalized Adults, 2017-2020.

  2021cited by this paper
• Estimated Cardiorespiratory Hospitalizations Attributable to Influenza and Respiratory Syncytial Virus Among Long-term Care Facility Residents

  2021cited by this paper
• Burden of noninfluenza respiratory viral infections in adults admitted to hospital: analysis of a multiyear Canadian surveillance cohort from 2 centres

  2021cited by this paper
• The Future of Respiratory Syncytial Virus Disease Prevention and Treatment

  2021cited by this paper
• Estimating the burden of adult hospital admissions due to RSV and other respiratory pathogens in England

  2021cited by this paper
• Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population

  2021cited by this paper
• Hospital utilization rates for influenza and RSV: a novel approach and critical assessment

  2021cited by this paper
• Epidemiology of respiratory syncytial virus across five influenza seasons among adults and children one year of age and older - Washington State, 2011/12 - 2015/16.

  2020cited by this paper
• The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis

  2020cited by this paper
• The health and economic burden of respiratory syncytial virus associated hospitalizations in adults

  2020cited by this paper
• Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach.

  2020cited by this paper
• Incidence of respiratory syncytial virus related health care utilization in the United States

  2020cited by this paper
• Respiratory syncytial virus infection in adults

  2019cited by this paper
• The Etiological Role of Common Respiratory Viruses in Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysis

  2019cited by this paper
• Burden of hospital admissions caused by respiratory syncytial virus (RSV) in infants in England: A data linkage modelling study.

  2019cited by this paper
• Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis.

  2019cited by this paper
• Estimating the burden on general practitioner services in England from increases in respiratory disease associated with seasonal respiratory pathogen activity

  2018cited by this paper
• Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007‐2012

  2017cited by this paper
• Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK

  2016cited by this paper
• Advances in RSV vaccine research and development - A global agenda.

  2016cited by this paper
• Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom

  2015cited by this paper
• The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy.

  2014cited by this paper
• Respiratory Syncytial Virus Infection in Adults

  2011cited by this paper
• Assessing the burden of influenza and other respiratory infections in England and Wales.

  2007cited by this paper
• Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study.

  2001cited by this paper
• Hospital admissions attributable to rotavirus infection in England and Wales.

  1996cited by this paper

• Real-world evidence on RSV vaccine uptake, effectiveness, and safety in older adults: a systematic review and meta-analysis.

  2026cites this paper
• Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective

  2026cites this paper
• The Potential Public Health Impact of the mRNA-Based Respiratory Syncytial Virus Vaccine, mRNA-1345, Under Extended Vaccination Campaigns Among Older Adults in the United Kingdom: A Modelling Study

  2025cites this paper
• Improving the accuracy of Respiratory Syncytial Virus (RSV) incidence estimates among hospitalised adults in Bristol, UK

  2025influential citation
• Burden of Respiratory Syncytial Virus infection in older adults hospitalised in England during 2023/24.

  2025cites this paper
• Addressing the Underestimated Burden of RSV in Older Adults in Europe: Epidemiology, Surveillance Gaps, and Public Health Implications

  2025cites this paper
• Estimating the respiratory syncytial virus-associated hospitalisation burden in older adults in European countries: a systematic analysis

  2025cites this paper
• Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017–2019

  2025cites this paper
• Frailty and delirium: A fatal combination in older adults

  2025cites this paper
• Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospitalisation among adults aged 75-79 years in England

  2025cites this paper
• Early evidence of RSV vaccination impact on hospitalisation rates of older people in Scotland.

  2025cites this paper
• Hospitalisation due to respiratory syncytial virus in a population-based cohort of older adults in Spain, 2016/17 to 2019/20

  2025cites this paper
• Prevalence of respiratory viruses in children with respiratory tract infections during the COVID-19 pandemic era: a systematic review and meta-analysis

  2025cites this paper
• Estimating the disease burden of respiratory syncytial virus (RSV) in older adults in England during the 2023/24 season: a new national hospital-based surveillance system

  2025influential citation
• Severity of Respiratory Viral Diseases and the Impacts of Underlying Medical Conditions During the Omicron Subvariant Dominant Epidemics—A Comparative Study of SARS-CoV-2, Influenza Virus and Respiratory Syncytial Virus

  2025cites this paper
• Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024–2025 Winter Season

  2025cites this paper
• Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75-79 years in England: a multicentre, test-negative, case-control study.

  2025cites this paper
• Effect of influenza vaccination on post-admission outcomes for influenza patients in England: a population-based cohort study.

  2025cites this paper
• Incidence and Burden of Respiratory Syncytial Virus-Associated Hospitalizations Among People 65 and Older in France: A National Hospital Database Study

  2025cites this paper
• Why the UK is vaccinating its older adult population against RSV-what geriatricians should know.

  2024cites this paper
• Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016–2019

  2024cites this paper
• Neutrophils and RSV: differences with age

  2024cites this paper
• Epidemiology and Disease Burden of Respiratory Syncytial Virus Infection in Adults

  2024cites this paper
• Best Practices for Identifying Hospitalized Lower Respiratory Tract Infections Using Administrative Data: A Systematic Literature Review of Validation Studies

  2024cites this paper
• Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis Protocol

  2024cites this paper
• Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019

  2024cites this paper
• Respiratory syncytial virus vs. Influenza virus infection: mortality and morbidity comparison over 7 epidemic seasons in an elderly population.

  2024cites this paper
• How Does the Burden of Respiratory Syncytial Virus Compare to Influenza in Spanish Adults?

  2024cites this paper
• Incidence of RSV in Adults: A Comprehensive Review of Observational Studies and Critical Gaps in Information

  2024cites this paper
• Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment

  2024cites this paper
• Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options

  2024cites this paper
• Clinical Characteristics of Virologically Confirmed Respiratory Syncytial Virus in English Primary Care: Protocol for an Observational Study of Acute Respiratory Infection

  2024cites this paper
• Hospitalization cost estimates of respiratory syncytial virus and influenza infections in adults in Spain, 2016-2019.

  2024cites this paper
• Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians

  2023cites this paper
• Estimation of the Number of Respiratory Syncytial Virus–Associated Hospitalizations in Adults in the European Union

  2023cites this paper
• Diabetes and bacterial co-infection are two independent risk factors for respiratory syncytial virus disease severity

  2023cites this paper
• Burden of respiratory syncytial virus in adults in the United Kingdom: A systematic literature review and gap analysis

  2023influential citation
• A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom

  2023cites this paper
• Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments.

  2023cites this paper
• Understanding the age spectrum of respiratory syncytial virus associated hospitalisation and mortality burden based on statistical modelling methods: a systematic analysis

  2023cites this paper
• Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?

  2023cites this paper
• Estimation of the number of RSV-associated hospitalisations in adults in the European Union

  2023influential citation
• Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study

  2023cites this paper
• Respiratory Syncytial Virus: An Uncommon Cause of Febrile Seizures—Results from a Systematic Review and Meta-Analysis

  2022cites this paper
• Rate of Hospitalizations and Mortality of Respiratory Syncytial Virus Infection Compared to Influenza in Older People: A Systematic Review and Meta-Analysis

  2022cites this paper
• Hospitalization costs of adult community-acquired pneumonia in England

  2022cites this paper
• Determinants of RSV epidemiology following suppression through pandemic contact restrictions

  2021cites this paper
• Estimating the burden of adult hospital admissions due to RSV and other respiratory pathogens in England

  2021cites this paper